Loading…

Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis

Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemi...

Full description

Saved in:
Bibliographic Details
Published in:Molecular cancer therapeutics 2013-08, Vol.12 (8), p.1591-1604
Main Authors: Petruccelli, Luca A, Pettersson, Filippa, Del Rincón, Sonia V, Guilbert, Cynthia, Licht, Jonathan D, Miller, Jr, Wilson H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243
cites cdi_FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243
container_end_page 1604
container_issue 8
container_start_page 1591
container_title Molecular cancer therapeutics
container_volume 12
creator Petruccelli, Luca A
Pettersson, Filippa
Del Rincón, Sonia V
Guilbert, Cynthia
Licht, Jonathan D
Miller, Jr, Wilson H
description Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemia (AML) cells expressing leukemia-associated fusion proteins (LAFP). HDIs have been shown to induce apoptosis, in part, through accumulation of DNA damage and inhibition of DNA repair. LAFPs have been correlated with a DNA repair-deficient phenotype, which may make them more sensitive to HDI-induced DNA damage. We found that expression of the LAFPs PLZF-RARα, PML-RARα, and RUNX1-ETO (AML1-ETO) increased sensitivity to DNA damage and apoptosis induced by the HDI vorinostat. The increase in apoptosis correlated with an enhanced downregulation of the prosurvival protein BCL2. Vorinostat also induced expression of the cell-cycle regulators p19(INK4D) and p21(WAF1) and triggered a G2-M cell cycle arrest to a greater extent in LAFP-expressing cells. The combination of LAFP and vorinostat further led to a greater downregulation of several base excision repair (BER) enzymes. These BER genes represent biomarker candidates for response to HDI-induced DNA damage. Notably, repair of vorinostat-induced DNA double-strand breaks was found to be impaired in PLZF-RARα-expressing cells, suggesting a mechanism by which LAFP expression and HDI treatment cooperate to cause an accumulation of damaged DNA. These data support the continued study of HDI-based treatment regimens in LAFP-positive AMLs.
doi_str_mv 10.1158/1535-7163.MCT-12-1039
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1420157396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1420157396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243</originalsourceid><addsrcrecordid>eNo9kd9u1TAMxiPExMbgEUC55KYjTpo2vZwO44-0jZtxHaWJwwJtU-oUcR5hb03PzuDKlv2zLX8fY29AXABo8x600lULjbq42d1VICsQqnvGzra6qYyG-vljfmRO2UuiH0KA6SS8YKdSadW0sj1jD1d_5gWJUp54jnzA9SeOyVWOKPvkCgYe18fuvOSCaSKeJr-gIyROOFEq6Xcqe14yv09U8oQ8oPNY9sPGbPB96lPJS5WmsPpt3YfbSx7c6L4jd1Pgbs5zyZToFTuJbiB8_RTP2bePV3e7z9X1109fdpfXlVe6KZWpRStCC8ph53ulRB1bF4UHI0WtTV-bPhrfdRpNiACy9lKibjD6PrQoa3XO3h33bg_9WpGKHRN5HAY3YV7JQi0F6FZ1zYbqI-qXTLRgtPOSRrfsLQh7cMEeFLYHhe3mggVpDy5sc2-fTqz9iOH_1D_Z1V8AF4bL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1420157396</pqid></control><display><type>article</type><title>Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Petruccelli, Luca A ; Pettersson, Filippa ; Del Rincón, Sonia V ; Guilbert, Cynthia ; Licht, Jonathan D ; Miller, Jr, Wilson H</creator><creatorcontrib>Petruccelli, Luca A ; Pettersson, Filippa ; Del Rincón, Sonia V ; Guilbert, Cynthia ; Licht, Jonathan D ; Miller, Jr, Wilson H</creatorcontrib><description>Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemia (AML) cells expressing leukemia-associated fusion proteins (LAFP). HDIs have been shown to induce apoptosis, in part, through accumulation of DNA damage and inhibition of DNA repair. LAFPs have been correlated with a DNA repair-deficient phenotype, which may make them more sensitive to HDI-induced DNA damage. We found that expression of the LAFPs PLZF-RARα, PML-RARα, and RUNX1-ETO (AML1-ETO) increased sensitivity to DNA damage and apoptosis induced by the HDI vorinostat. The increase in apoptosis correlated with an enhanced downregulation of the prosurvival protein BCL2. Vorinostat also induced expression of the cell-cycle regulators p19(INK4D) and p21(WAF1) and triggered a G2-M cell cycle arrest to a greater extent in LAFP-expressing cells. The combination of LAFP and vorinostat further led to a greater downregulation of several base excision repair (BER) enzymes. These BER genes represent biomarker candidates for response to HDI-induced DNA damage. Notably, repair of vorinostat-induced DNA double-strand breaks was found to be impaired in PLZF-RARα-expressing cells, suggesting a mechanism by which LAFP expression and HDI treatment cooperate to cause an accumulation of damaged DNA. These data support the continued study of HDI-based treatment regimens in LAFP-positive AMLs.</description><identifier>ISSN: 1535-7163</identifier><identifier>EISSN: 1538-8514</identifier><identifier>DOI: 10.1158/1535-7163.MCT-12-1039</identifier><identifier>PMID: 23536727</identifier><language>eng</language><publisher>United States</publisher><subject>Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; Apoptosis - genetics ; Cell Line, Tumor ; DNA Damage - drug effects ; DNA Repair ; Drug Resistance, Neoplasm - genetics ; Gene Expression Regulation, Leukemic ; Histone Deacetylase Inhibitors - chemistry ; Histone Deacetylase Inhibitors - pharmacology ; Humans ; Hydroxamic Acids - chemistry ; Hydroxamic Acids - pharmacology ; Leukemia, Myeloid, Acute - genetics ; Oncogene Proteins, Fusion - genetics</subject><ispartof>Molecular cancer therapeutics, 2013-08, Vol.12 (8), p.1591-1604</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243</citedby><cites>FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23536727$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Petruccelli, Luca A</creatorcontrib><creatorcontrib>Pettersson, Filippa</creatorcontrib><creatorcontrib>Del Rincón, Sonia V</creatorcontrib><creatorcontrib>Guilbert, Cynthia</creatorcontrib><creatorcontrib>Licht, Jonathan D</creatorcontrib><creatorcontrib>Miller, Jr, Wilson H</creatorcontrib><title>Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis</title><title>Molecular cancer therapeutics</title><addtitle>Mol Cancer Ther</addtitle><description>Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemia (AML) cells expressing leukemia-associated fusion proteins (LAFP). HDIs have been shown to induce apoptosis, in part, through accumulation of DNA damage and inhibition of DNA repair. LAFPs have been correlated with a DNA repair-deficient phenotype, which may make them more sensitive to HDI-induced DNA damage. We found that expression of the LAFPs PLZF-RARα, PML-RARα, and RUNX1-ETO (AML1-ETO) increased sensitivity to DNA damage and apoptosis induced by the HDI vorinostat. The increase in apoptosis correlated with an enhanced downregulation of the prosurvival protein BCL2. Vorinostat also induced expression of the cell-cycle regulators p19(INK4D) and p21(WAF1) and triggered a G2-M cell cycle arrest to a greater extent in LAFP-expressing cells. The combination of LAFP and vorinostat further led to a greater downregulation of several base excision repair (BER) enzymes. These BER genes represent biomarker candidates for response to HDI-induced DNA damage. Notably, repair of vorinostat-induced DNA double-strand breaks was found to be impaired in PLZF-RARα-expressing cells, suggesting a mechanism by which LAFP expression and HDI treatment cooperate to cause an accumulation of damaged DNA. These data support the continued study of HDI-based treatment regimens in LAFP-positive AMLs.</description><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - genetics</subject><subject>Cell Line, Tumor</subject><subject>DNA Damage - drug effects</subject><subject>DNA Repair</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>Gene Expression Regulation, Leukemic</subject><subject>Histone Deacetylase Inhibitors - chemistry</subject><subject>Histone Deacetylase Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Hydroxamic Acids - chemistry</subject><subject>Hydroxamic Acids - pharmacology</subject><subject>Leukemia, Myeloid, Acute - genetics</subject><subject>Oncogene Proteins, Fusion - genetics</subject><issn>1535-7163</issn><issn>1538-8514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNo9kd9u1TAMxiPExMbgEUC55KYjTpo2vZwO44-0jZtxHaWJwwJtU-oUcR5hb03PzuDKlv2zLX8fY29AXABo8x600lULjbq42d1VICsQqnvGzra6qYyG-vljfmRO2UuiH0KA6SS8YKdSadW0sj1jD1d_5gWJUp54jnzA9SeOyVWOKPvkCgYe18fuvOSCaSKeJr-gIyROOFEq6Xcqe14yv09U8oQ8oPNY9sPGbPB96lPJS5WmsPpt3YfbSx7c6L4jd1Pgbs5zyZToFTuJbiB8_RTP2bePV3e7z9X1109fdpfXlVe6KZWpRStCC8ph53ulRB1bF4UHI0WtTV-bPhrfdRpNiACy9lKibjD6PrQoa3XO3h33bg_9WpGKHRN5HAY3YV7JQi0F6FZ1zYbqI-qXTLRgtPOSRrfsLQh7cMEeFLYHhe3mggVpDy5sc2-fTqz9iOH_1D_Z1V8AF4bL</recordid><startdate>201308</startdate><enddate>201308</enddate><creator>Petruccelli, Luca A</creator><creator>Pettersson, Filippa</creator><creator>Del Rincón, Sonia V</creator><creator>Guilbert, Cynthia</creator><creator>Licht, Jonathan D</creator><creator>Miller, Jr, Wilson H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201308</creationdate><title>Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis</title><author>Petruccelli, Luca A ; Pettersson, Filippa ; Del Rincón, Sonia V ; Guilbert, Cynthia ; Licht, Jonathan D ; Miller, Jr, Wilson H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - genetics</topic><topic>Cell Line, Tumor</topic><topic>DNA Damage - drug effects</topic><topic>DNA Repair</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>Gene Expression Regulation, Leukemic</topic><topic>Histone Deacetylase Inhibitors - chemistry</topic><topic>Histone Deacetylase Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Hydroxamic Acids - chemistry</topic><topic>Hydroxamic Acids - pharmacology</topic><topic>Leukemia, Myeloid, Acute - genetics</topic><topic>Oncogene Proteins, Fusion - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Petruccelli, Luca A</creatorcontrib><creatorcontrib>Pettersson, Filippa</creatorcontrib><creatorcontrib>Del Rincón, Sonia V</creatorcontrib><creatorcontrib>Guilbert, Cynthia</creatorcontrib><creatorcontrib>Licht, Jonathan D</creatorcontrib><creatorcontrib>Miller, Jr, Wilson H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular cancer therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petruccelli, Luca A</au><au>Pettersson, Filippa</au><au>Del Rincón, Sonia V</au><au>Guilbert, Cynthia</au><au>Licht, Jonathan D</au><au>Miller, Jr, Wilson H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis</atitle><jtitle>Molecular cancer therapeutics</jtitle><addtitle>Mol Cancer Ther</addtitle><date>2013-08</date><risdate>2013</risdate><volume>12</volume><issue>8</issue><spage>1591</spage><epage>1604</epage><pages>1591-1604</pages><issn>1535-7163</issn><eissn>1538-8514</eissn><abstract>Histone deacetylase inhibitors (HDI) show activity in a broad range of hematologic and solid malignancies, yet the percentage of patients in any given malignancy who experience a meaningful clinical response remains small. In this study, we sought to investigate HDI efficacy in acute myeloid leukemia (AML) cells expressing leukemia-associated fusion proteins (LAFP). HDIs have been shown to induce apoptosis, in part, through accumulation of DNA damage and inhibition of DNA repair. LAFPs have been correlated with a DNA repair-deficient phenotype, which may make them more sensitive to HDI-induced DNA damage. We found that expression of the LAFPs PLZF-RARα, PML-RARα, and RUNX1-ETO (AML1-ETO) increased sensitivity to DNA damage and apoptosis induced by the HDI vorinostat. The increase in apoptosis correlated with an enhanced downregulation of the prosurvival protein BCL2. Vorinostat also induced expression of the cell-cycle regulators p19(INK4D) and p21(WAF1) and triggered a G2-M cell cycle arrest to a greater extent in LAFP-expressing cells. The combination of LAFP and vorinostat further led to a greater downregulation of several base excision repair (BER) enzymes. These BER genes represent biomarker candidates for response to HDI-induced DNA damage. Notably, repair of vorinostat-induced DNA double-strand breaks was found to be impaired in PLZF-RARα-expressing cells, suggesting a mechanism by which LAFP expression and HDI treatment cooperate to cause an accumulation of damaged DNA. These data support the continued study of HDI-based treatment regimens in LAFP-positive AMLs.</abstract><cop>United States</cop><pmid>23536727</pmid><doi>10.1158/1535-7163.MCT-12-1039</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1535-7163
ispartof Molecular cancer therapeutics, 2013-08, Vol.12 (8), p.1591-1604
issn 1535-7163
1538-8514
language eng
recordid cdi_proquest_miscellaneous_1420157396
source Free E-Journal (出版社公開部分のみ)
subjects Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Apoptosis - drug effects
Apoptosis - genetics
Cell Line, Tumor
DNA Damage - drug effects
DNA Repair
Drug Resistance, Neoplasm - genetics
Gene Expression Regulation, Leukemic
Histone Deacetylase Inhibitors - chemistry
Histone Deacetylase Inhibitors - pharmacology
Humans
Hydroxamic Acids - chemistry
Hydroxamic Acids - pharmacology
Leukemia, Myeloid, Acute - genetics
Oncogene Proteins, Fusion - genetics
title Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A55%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20leukemia-associated%20fusion%20proteins%20increases%20sensitivity%20to%20histone%20deacetylase%20inhibitor-induced%20DNA%20damage%20and%20apoptosis&rft.jtitle=Molecular%20cancer%20therapeutics&rft.au=Petruccelli,%20Luca%20A&rft.date=2013-08&rft.volume=12&rft.issue=8&rft.spage=1591&rft.epage=1604&rft.pages=1591-1604&rft.issn=1535-7163&rft.eissn=1538-8514&rft_id=info:doi/10.1158/1535-7163.MCT-12-1039&rft_dat=%3Cproquest_cross%3E1420157396%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-84070d713ae9cb3304f7af0c1820458b48bf8c995e8df1124c22e56efcbd7e243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1420157396&rft_id=info:pmid/23536727&rfr_iscdi=true